MedPath

Effects of Vibration Training on Exercise Capacity in COPD-patients

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Other: whole body vibration training
Registration Number
NCT01380639
Lead Sponsor
Schön Klinik Berchtesgadener Land
Brief Summary

The aim of this study is to investigate the exercise capacity in COPD-patients performing a vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a rehabilitation program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Chronic obstructive pulmonary disease III/IV
Exclusion Criteria
  • Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
  • Severe disease other than COPD, that could influence the results of the study
  • Abuse of alcohol or drugs
  • Simultaneously participation in another study
  • Tachypnea (>30/min)
  • Severe exacerbation during rehabilitation
  • Cardiac insufficiency (NYHA IV)
  • Myocardial infarction during the last 6 weeks
  • Mental-health problem
  • Pregnancy
  • Known HIV-infection
  • Slipped disk
  • Acute discopathy
  • Acute thrombosis
  • Implants in trained regions of the body (lower extremities)
  • Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis
  • Acute tendinopathy in trained regions of the body
  • Acute hernia
  • Fresh fractures, wounds or scars in trained regions of the body
  • Gallstones or stones in the urinary tract collection system

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Rehabilitation with vibration trainingwhole body vibration training-
Primary Outcome Measures
NameTimeMethod
6-Minute-Walking-Distanceday 1, day 19

Change in 6-minute-walking-distance from baseline to day 19

Secondary Outcome Measures
NameTimeMethod
Isometric Maximum Handgrip Forceday 1, day 19

change in isometric max. handgrip force from baseline to day 19

Arterial Blood Gasday 1
Brain Natruretic Peptide (BNP)day 1, day 19

change in BNP from baseline to day 19

BODE-Scoreday 1, day 19

Change in Bode-Score from baseline to day 19

Body Compositionday 1 and 19

Change in body composition from baseline to day 19

Lung Functionday 1

Trial Locations

Locations (1)

Schön Klinikum Berchtesgadener Land

🇩🇪

Schönau am Königssee, Germany

© Copyright 2025. All Rights Reserved by MedPath